Document:

Equity Transfer Agreement, dated as of November 10, 2006

 Exhibit 10.17 
 English translation of the executed copy 
 The Equity Transfer Agreement Regarding 
 Liaoning Sunshine Bio-Pharmaceutical Company Limited 
 Between 
 Shenyang Sunshine Pharmaceutical Company Limited 
 And 
 Dan Lou 

 EQUITY TRANSFER AGREEMENT 
 THIS AGREEMENT is entered into by and between the following parties in Shenyang City of Liaoning Province on November 10, 2006: 
 The Transferor: Shenyang Sunshine Pharmaceutical Company Limited 
 Legal Address: No. 3 A1, Road 10,
Shenyang Economy & Technology Development Zone 
 Legal Representative: Dan Lou 
 The Transferee: Dan Lou 
 Identity
Cared Number: 210102193503076017 
 Whereas: 
  

	1.	The Transferor is a foreign invested wholly owned enterprise established and validly subsisted according to the laws of the People’s Republic of China (hereinafter the
“PRC”), which is holding 90% equity of Liaoning Sunshine Pharmaceutical Company Limited (hereinafter the “Liaoning Sunshine”) (hereinafter the “Subject Equity”); 

  

	2.	The Transferee is a legitimate Chinese citizen, who is legally qualified to take up the transferred equity of Beijing Sunshine according to relevant laws; 

 

	3.	Liaoning Sunshine is a company with limited liability incorporated and validly subsisted according to the laws of the PRC, the business scope of which covers the sale of
bio-products (including bio-pharmaceuticals), biochemical medicines, chemical preparations, antibiotics, prepared traditional Chinese medicines (efficacious before 31 December 2009) and diagnostic medicines; the sale of three types of medical
equipment (excluding throwaway aseptic medical appliances (efficacious before 31 December 2009); the manufacture, sale of special nutrition food; the self-operation and agency of various commodities and technologies and their export and import
(excluding those under restricted operation or prohibited to import and export by the State). Its registered capital is RMB 15 million, which is fully paid up, with the Transferor and Shenyang Keweier Advanced Technology Co., Ltd. as existing
shareholders, Shenyang Keweier Advanced Technology Co., Ltd. holding 10% equity interest and the Transferor 90% in Liaoning Sunshine; 

  

 1 

	4.	The Transferor agrees to transfer and the Transferee agrees to acquire the Subject Equity according to the stipulated terms and conditions of this Agreement.

 Accordingly, the Transferor and the Transferee reach an agreement as follows: 
 I Equity Transfer 
  

	1.	The Transferor shall transfer the Subject Equity to the Transferee according to the stipulations of this Agreement. 

  

	2.	The Transferee shall acquire the Subject Equity according to the stipulations of this Agreement. 

  

	3.	With effect from the day on which this Agreement takes effect and Liaoning Sunshine has completed the procedures for change of industrial and commercial registration, the Transferee
shall become the legal owner of the Subject Equity, enjoying and bearing all rights and obligations in relation to the Subject Equity; whereas the Transferor shall no longer enjoy any rights in relation to the Subject Equity, nor bear any
obligations and liabilities in relation to the Subject Equity, except with those agreed separately by the Parties hereto. The Transferor shall have the obligation to render assistance in the completion of all necessary legal procedures relating to
the transfer of Subject Equity by the Transferee and Liaoning Sunshine. 

 II Equity Transfer Price and its Settlement

  

	1.	As agreed after consultation by the Transferor and the Transferee, the price for the transfer of the Subject Equity is ascertained to be RMB 13.5 million; 

 

	2.	The Parties hereto agree that the Transferee shall settle the transfer price in RMB, the specific payment method of which shall be that the Transferee shall make full payment within
6 months after the signing of this Agreement; 

  

	3.	Taxes due to be paid in relation to this transfer of equity shall be paid by the Parties hereto according to relevant laws and regulations. 

  

 2 

 III Validity 
 This Agreement shall take effect from the day on which it is signed by the respective authorized representatives of both parties. 
 IV Representations and Warranties of the Transferor 
 The Transferor hereby represents and warrants as follows:

  

	1.	The Transferor is the legal person of the enterprise duly established and validly subsisted according to the laws of the PRC, and it has all necessary rights, powers and capacity to
execute and perform any obligations and liabilities under this Agreement; and this Agreement shall be of legal and effective binding force on the Transferor once it is signed. 

  

	2.	The Transferor undertakes that the equity to be transferred is free from any pledge or other guarantee, or any third party claim. 

  

	3.	The Transferor and Liaoning Sunshine have not withheld any fact relating to Liaoning Sunshine that if disclosed would hinder the execution of this Agreement, or would cause the
change of meaning of any clause in this Agreement. 

  

	4.	After the transfer of the Subject Equity to the Transferee, the above representations, warranties and commitments shall persist and take effect. 

 V Representations and Warranties of the Transferee 
 The Transferee hereby represents and warrants as follows: 
  

	1.	The Transferee is a legitimate Chinese citizen, and has all necessary rights, powers and capacity to execute and perform any obligations and liabilities under this Agreement; and
this Agreement shall be of legal and effective binding force on the Transferee once it is signed. 

  

	2.	The execution, delivery and performance of this Agreement by the Transferee contravene no law, administrative regulation, transferee’s constitution or other similar documents,
nor do they breach any contract, rule, verdict or adjudication made by any court or arbitration body that are binding on the Transferee or its property. 

  

 3 

	3.	After the completion of transfer of the Subject Equity, the above representations, warranties and commitments shall persist and take effect. 

 VI Confidentiality 
 Unless as required by
relevant laws and regulations of the PRC, or by relevant competent government departments, without the consent of the other party, either party shall not, before the completion of the transaction contemplated in this Agreement, disclose any content
of this Agreement to any third person other than the parties involved in such transaction. 
 VII Open Terms of this Agreement 
 Both the Transferor and the Transferee agree that, after signing this Agreement, any open terms of this Agreement is subject to further negotiation and a
supplementary agreement. Such supplementary agreement shall form an integral part of this Agreement. 
 VIII Default Liability 
 Either party breaching any representation, warranty or undertaking made by it under this Agreement, or any article in this Agreement shall constitute a
default. The defaulting party shall compensate the non-defaulting party fully and adequately. 
 IX Settlement of Disputes 
 Any dispute over this Agreement arisen in the performance of the same shall be settled by the Parties hereto through friendly consultation. In case the
dispute cannot be settled through consultation, either party may sue at a court in the PRC with competent jurisdiction against the other party. 
 X
Governing Law 
 The execution, validity, interpretation, performance of this Agreement, and the settlement of disputes hereof, all
are governed by the laws of the PRC. 
  

 4 

 XI Rights under this Agreement 
 Without the written consent of the other party, either party shall not transfer its rights under this Agreement. This Agreement shall be binding on the
successors and approved transferees of both parties. 
 XII Language of the Context 
 This Agreement is written in Chinese. The original is made in triplicate, with the Transferor, the Transferee and Liaoning Sunshine each retaining one
copy thereof, respectively. Each original shall be of the same legal validity. 
 IN WITNESS WHEREOF, the Transferor and the Transferee hereby
formally authorize their respective representatives to sign this Agreement as of the date and in the place first above written. 
 The Transferee:
Shenyang Sunshine Pharmaceutical Company Limited 
 Authorized Representative: /s/ Dan Lou (affixed with the company seal of Shenyang Sunshine
Pharmaceutical Company Limited) 
  

			
	The Transferee: Lou Dan
		
	Signature:	 	 /s/ Dan Lou

  

 5Form of Purchase Agreement

 Exhibit 10.18 
 English translation of the executed copy 
 Purchase Agreement for Acquisition of Equity Interest

 In 
 Liaoning
Sunshine Bio-Pharmaceutical Company Limited 
 Between 
 Shenyang Sunshine Pharmaceutical Company Limited 
 And 
 Dan Lou 

 PURCHASE AGREEMENT FOR ACQUISITION OF EQUITY INTEREST 
 THIS AGREEMENT is entered into between the following parties in Shenyang City, Liaoning Province on December 1, 2006: 
 Party A: Shenyang Sunshine Pharmaceutical Company Limited 
  

	Legal	Address: No. 3 A1, Road 10, Shenyang Economy & Technology Development Zone 

 Legal Representative: Dan Lou 
 Party B: Dan Lou 
 Identity Card Number: 210102193503076017 
 WHEREAS, 
  

	1.	Party A is a foreign invested wholly owned enterprise established and validly subsisted according to the laws of the People’s Republic of China (hereinafter the
“PRC”), which was originally holding 90% equity of Liaoning Sunshine Pharmaceutical Company Limited (hereinafter “Liaoning Sunshine”), all of which was transferred to Party B pursuant to an Equity Transfer Agreement entered into
with Party B on November 10, 2006; 

  

	2.	Party B is a legitimate Chinese citizen. On November 10, 2006, Party B and Party A entered into an Equity Transfer Agreement pursuant to which Party B acquired from Party A
90% equity of Liaoning Sunshine; Party B also entered into another equity transfer agreement pursuant to which Party B acquired from Shenyang Keweier Advance Technology Company Limited 10% equity of Liaoning Sunshine. The registration process for
the relevant transfers has been completed. As of the date hereof, Party B is legally holding 100% equity of Liaoning Sunshine (“Subject Equity”); 

  

	3.	Liaoning Sunshine is a company with limited liability incorporated and validly subsisted according to the laws of the PRC, the business scope of which covers the sale of
bio-products (including bio-pharmaceuticals), biochemical medicines, chemical preparations, antibiotics, prepared traditional Chinese medicines (efficacious before 31 December 2009) and diagnostic medicines; the sale of three types of medical
equipment (items subject to approval by licneses (efficacious before August 17, 2010); the manufacture, sale of special nutrition food; the self-operation and agency of various commodities and technologies and their export and import (excluding
those under restricted operation or prohibited to import and export by the State). Its registered capital is RMB 15 million. Party B, through equity transfer, becomes the legitimate shareholder of Liaoning Sunshine; 

  

 1 

	4.	Party B is willing to transfer to Party A the Subject Equity upon the satisfaction of the conditions under this Agreement. 

 After friendly consultation, the Parties hereto hereby reach an agreement as follows: 
  

			
	Article 1	  	Party B hereby agrees to transfer to Party A the Subject Equity at the price as determined under Article 2 hereof and change the title of the Subject Equity under the name of Party A upon the
satisfaction of the following condition precedent: the relevant PRC government approval, if any, has been obtained to permit Party A’s holding the Subject Equity.
		
	Article 2	  	Both parties agree that the price for Party A to purchase the Subject Equity is RMB15 million.
		
	Article 3	  	Party A shall pay RMB13.5 million as down payment for the purchase of the Subject Equity within 30 days after the signing of this Agreement, the remaining balance of RMB 1.5 million shall be
paid after the title of the Subject Equity is transferred to and under the name of Party A.
		
	Article 4	  	Upon the request of Party A, Party B shall provide all necessary assistance and shall cause Liaoning Sunshine to take all necessary actions to cooperate with Party A in the legitimate and
successful completion of the acquisition of the Subject Equity, including but not limited to applying for and obtaining the approval from the relevant PRC government departments regarding the acquisition. Party B shall timely provide Party A with
all the correspondence with the relevant PRC government departments related to the relevant application and approval regarding the acquisition or explanation for its communication with the approval authority.

  

 2 

			
	Article 5	  	Party B shall carry out all necessary legal proceedings to ensure that Liaoning Sunshine is legitimately and duly existing and holding all legitimate and effective licenses, permits and
certificates necessary for its business operation.
		
	Article 6	  	Unless obtaining Party A’s prior written consent, Party B shall not transfer or otherwise dispose of the Subject Equity to any third party other than Party A and shall ensure that
Liaoning Sunshine does not increase or decrease its registered capital or issue any bonds or debts.
		
	Article 7	  	The parties agree that should Party A fail to complete all procedures under law to acquire the Subject Equity within 10 years after the signing of this Agreement as a result of restriction
under PRC law or being unable to obtain PRC government approval, Party A shall have the right to terminate this Agreement unilaterally and Party B shall return any and all payment made by Party A hereunder.
		
	Article 8	  	This Agreement shall take effect from the date on which it is signed by the respective authorized representatives of the Parties hereto.
		
	Article 9	  	Unless otherwise provided hereunder, without the consent of the other party, either party shall not, before the completion of the transaction contemplated in this Agreement, disclose any
content of this Agreement to any third person other than the parties involved in such transaction.

  

 3 

			
	Article 10	  	Neither party shall be deemed as disclosing any content of this Agreement under the following circumstances: (1) the confidential information comes into the public domain prior to such
disclosure (except for disclosure under a breach of this provision); (2) the disclosure is mandatory required by any government authority, by the relevant securities supervision authorities or under any laws and regulations.
		
	Article 11	  	Both parties agree that, after signing this Agreement, any open terms of this Agreement is subject to further negotiation and a supplementary agreement. Such supplementary agreement shall
form an integral part of this Agreement.
		
	Article 12	  	Either party breaching any clause in this Agreement shall constitute a default. The defaulting party shall compensate the non-defaulting party fully and adequately.
		
	Article 13	  	Upon the occurrence of any of the following circumstances, Party A shall have the right to terminate this Agreement and Party B shall refund Party A all payment made hereunder by Party A: (1)
Party A fails to complete all procedures under law to acquire the Subject Equity within 10 years after the signing of this Agreement due to reasons caused by Party B; (2) Liaoning Sunshine loses its legal person status as a result of cancellation or
ceasing its business license; or (3) any license, permit and certificate necessary for the business operation of Liaoning Sunshine is cancelled, withdrawn or expired and cannot be extended or renewed within reasonable period of time
		
	Article 14	  	Any dispute over this Agreement arisen in the performance of the same shall be settled by the Parties hereto through friendly consultation. In case the dispute cannot be settled through
consultation, either party may sue at a court in the PRC with competent jurisdiction against the other party.

  

 4 

			
	Article 15	  	The execution, validity, interpretation, performance of this Agreement, and the settlement of disputes hereof, all are governed by the laws of the PRC.
		
	Article 16	  	Without the written consent of the other party, either party shall not transfer its rights under this Agreement. This Agreement shall be binding on the successors and approved transferees of
both parties.
		
	Article 17	  	This Agreement is made in duplicate, with Party A and Party B each retaining one copy thereof, respectively. Each original shall be of the same legal validity.

 IN WITNESS WHEREOF, the Parties hereof hereby formally authorize their respective representatives
to sign this Agreement as of the date and in the place first above written. 
 Party A: Shenyang Sunshine Pharmaceutical Company Limited 

Authorized Representative: /s/ Dan Lou (affixed with the company seal of Shenyang Sunshine Pharmaceutical Company Limited) 
  

			
	Party B: Dan Lou
		
	Signature:	 	 /s/ Dan Lou

  

 5 

 Schedule A 
 Purchase
Agreement for the Acquisition of Equity Interest in Beijing Sunshine Bio-product Sales Company Limited, or Beijing Sunshine, which is substantially identical to Exhibit 10.18 except as to: 
  

			
	Purchasing party:	  	Shenyang Sunshine Pharmaceutical Company Limited
		
	Selling parties:	  	Dongmei Su (holding 45% equity interest in Beijing Sunshine), and
		  	Shenyang Keweier Advance Technology Co., Ltd. (holding 55% equity interest in Beijing Sunshine)
		
	Date:	  	December 15, 2006
		
	Purchase price:	  	RMB450,000 for 45% equity interest held by Dongmei Su
		  	RMB550,000 for 55% equity interest held by Shenyang Keweier

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}]]